These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16776263)

  • 1. [Malignant pheochromocytoma].
    Tanabe A; Tsuiki M; Takano K; Naruse M
    Nihon Rinsho; 2006 May; Suppl 1():739-43. PubMed ID: 16776263
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pheochromocytoma].
    Arai H; Nakao K
    Nihon Rinsho; 2006 May; Suppl 1():724-9. PubMed ID: 16776260
    [No Abstract]   [Full Text] [Related]  

  • 3. [Malignant pheochromocytoma responsive to multimodal therapy: a case report].
    Mukai M; Kanno N; Nakagawa M; Uemura M; Nishimura K; Miyoshi S; Yoshida K; Kawano K
    Hinyokika Kiyo; 2003 Oct; 49(10):583-5. PubMed ID: 14655600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical review: Current treatment of malignant pheochromocytoma.
    Scholz T; Eisenhofer G; Pacak K; Dralle H; Lehnert H
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1217-25. PubMed ID: 17284633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of metastatic pheochromocytoma with remarkable response to combination of cyclophosphamide, vincristine and dacarbazine].
    Naoi Y; Tamaki Y; Ooka M; Tsukamoto F; Miyoshi Y; Tanji Y; Taguchi T; Noguchi S
    Gan To Kagaku Ryoho; 2003 Jan; 30(1):145-9. PubMed ID: 12557721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis and management of pheochromocytoma.
    Hodin R; Lubitz C; Phitayakorn R; Stephen A
    Curr Probl Surg; 2014 Apr; 51(4):151-87. PubMed ID: 24636619
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapy of malignant pheochromocytoma. Invitation to participate in a randomized multicenter study].
    Mundschenk J; Kopf D; Lehnert H
    Dtsch Med Wochenschr; 1998 Jan; 123(1-2):32-3. PubMed ID: 9465855
    [No Abstract]   [Full Text] [Related]  

  • 8. Pheochromocytoma: implications in tumorigenesis and the actual management.
    Shah U; Giubellino A; Pacak K
    Minerva Endocrinol; 2012 Jun; 37(2):141-56. PubMed ID: 22691888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of Sipple's syndrome with malignant pheochromocytoma treated with 131I-metaiodobenzyl guanidine and a combined chemotherapy with cyclophosphamide, vincristine and dacarbazine.
    Sasaki M; Iwaoka T; Yamauchi J; Tokunaga H; Naomi S; Inoue J; Oishi S; Umeda T; Sato T
    Endocr J; 1994 Apr; 41(2):155-60. PubMed ID: 7951563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of malignant pheochromocytoma treated with 131I-metaiodobenzylguanidine and CVD regimen].
    Ukimura O; Kojima M; Hosoi S; Itoh H; Watanabe H; Minamikawa T
    Nihon Hinyokika Gakkai Zasshi; 1994 May; 85(5):811-4. PubMed ID: 8022145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy.
    Mastrangelo S; Tornesello A; Diociaiuti L; Pession A; Prete A; Rufini V; Troncone L; Mastrangelo R
    Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of advanced neuroblastoma in children over 1 year of age: the critical role of ¹³¹I-metaiodobenzylguanidine combined with chemotherapy in a rapid induction regimen.
    Mastrangelo S; Rufini V; Ruggiero A; Di Giannatale A; Riccardi R
    Pediatr Blood Cancer; 2011 Jul; 56(7):1032-40. PubMed ID: 21344615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and management of pheochromocytoma.
    Feldman JM
    Hosp Pract (Off Ed); 1989 Jan; 24(1):175-9, 182, 187-9 passim. PubMed ID: 2492031
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of malignant pheochromocytoma with successful control of systemic metastasis with CVD chemotherapy].
    Minami T; Doi Y; Tetsuo H; Baba K; Seto S; Suzuki S; Hayano M; Yano S; Minami K; Oshibuchi E
    Nihon Naika Gakkai Zasshi; 1996 Dec; 85(12):2078-80. PubMed ID: 9036176
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pheochromocytoma].
    Suzuki S; Abe T; Ito S
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():284-9. PubMed ID: 15506388
    [No Abstract]   [Full Text] [Related]  

  • 16. Flushing, pheochromocytoma, and the dermatologist.
    Heymann WR
    J Am Acad Dermatol; 2006 Dec; 55(6):1075-7. PubMed ID: 17110222
    [No Abstract]   [Full Text] [Related]  

  • 17. [Benign and malignant pheochromocytoma].
    Lehnert H; Hahn K; Dralle H
    Internist (Berl); 2002 Feb; 43(2):196, 199-209. PubMed ID: 11963757
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of malignant phaeochromocytoma.
    El-Modir A; Awwad S
    Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):261. PubMed ID: 12109835
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Fishbein L; Ben-Maimon S; Keefe S; Cengel K; Pryma DA; Loaiza-Bonilla A; Fraker DL; Nathanson KL; Cohen DL
    Endocr Relat Cancer; 2017 Aug; 24(8):L51-L55. PubMed ID: 28566531
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recurrent hypertensive crises and dyspnea following unilateral adrenalectomy in pheochromocytoma in a 44-year-old patient. Successful combination chemotherapy of malignant pheochromocytoma].
    Saller B; Jacob K; Markl A; Zwiebel FM; Engelhardt D; Mann K
    Internist (Berl); 1990 Jan; 31(1):78-81. PubMed ID: 2307558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.